About Us

Redamancy Companion is a specialist research and intelligence platform dedicated to the rapidly evolving field of AI companion technology. Operated by The Vanderbilt Portfolio AG from Zug, Switzerland, our platform delivers rigorous, data-driven analysis of the technologies reshaping human connection in the digital age.

The word “redamancy” means the act of loving in return — a concept that captures the essence of what AI companion technology aspires to achieve. Our mission is to illuminate how artificial intelligence is being designed, deployed, and regulated to address one of the most pressing public health challenges of our era: the global loneliness epidemic.

Our Coverage

Our editorial team produces in-depth intelligence across several interconnected domains:

Digital Companions for Elderly Care — We track the development and deployment of AI-powered companions designed to provide cognitive stimulation, emotional support, and social engagement for aging populations. From robotic assistants to conversational AI platforms, we analyse the technologies that are transforming geriatric care delivery.

AI Friendship Applications — We monitor the consumer AI companion market, including platforms like Replika, Character.AI, and emerging competitors. Our analysis covers user engagement metrics, monetisation models, psychological impact research, and the competitive landscape.

Therapeutic AI Assistants — We cover the intersection of AI and mental health, examining clinical AI chatbots, digital cognitive behavioural therapy tools, and AI-augmented therapeutic platforms. Our reporting includes regulatory developments, clinical trial data, and efficacy research.

Loneliness Epidemic Technology Solutions — We provide strategic analysis of how technology companies, healthcare systems, and governments are leveraging AI to address social isolation. Our coverage spans policy frameworks, public health initiatives, and private sector innovation.

Editorial Standards

All content published on Redamancy Companion adheres to the editorial standards of The Vanderbilt Portfolio AG. Our research draws upon official government publications, peer-reviewed academic research, industry databases, regulatory filings, and proprietary analysis. Figures presented are indicative and updated periodically. Nothing published on this platform constitutes investment, medical, or legal advice.

Contact

For editorial enquiries, research partnerships, or corrections, please visit our Contact page.